Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Pfizer drug “significantly reduces” risk of heart-attack, stroke

Pfizer drug “significantly reduces” risk of heart-attack, stroke

23rd May 2008

High doses of Lipitor (atorvastatin calcium) can help prevent major cardiovascular events including heart attack and stroke, Pfizer says.

Its studies show a 27 per cent decrease in risk for patients with heart disease and a history of coronary bypass who took 80mg of Lipitor, compared to those on a 10mg dose.

Pfizer also concluded that intensive Lipitor therapy also provided a 30 per cent reduction in the need for repeat coronary bypass surgery or angioplasty, compared with Lipitor administered at 10mg.

Dr Rochelle Chaiken, vice-president of Pfizer’s global cardiovascular and metabolic medical team, said that many patients believed that once they had undergone coronary bypass surgery they were no longer at risk from cardiovascular events.

“Although these patients continue to be at an increased risk ? statins are considerably underused,” she added.

“This analysis highlights not only the importance of treating, but also treating aggressively with Lipitor 80mg.”

Every year an estimated 150,000 people in the UK have a stroke, according to figures from the Stroke Association.

We currently have 5 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.